PATENT CLAIM ANALYSIS

Application Number: 16206448
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["424", "186100"]

Abstract:
The present invention provides recombinant adenoviral compositions and methods for their use in treating disorders associated with epithelial tissues.

Claim (Index 18):
The recombinant AdB-2/3 fiber polypeptide of  claim 14 , wherein the AdB-2/3 fiber polypeptide homotrimer comprises a dimer of the homotrimer.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 98.0
- Lexical Diversity: 1.0
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15593578', '14429803', '13158246', '14066353', '15538975']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7900730719294884
- 35 USC 102 Novelty (BERT): 0.7178212804773714
- Combined Prediction Score: 0.7828478927842767
- Mean Citation Score: 620.776718
- Max Citation Score: 795.7945599999997
- Similarity Product: 749.184234225044

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test